Lung cancer screening in the population aged 55-75 years using low-dose computed tomography (LDCT) scan in Chiang Kham Hospital Phayao, Thailand: A Cross-Sectional Observational Pilot Study

Authors

  • Kritsada Thanawutthikul Department of Internal Medicine, ChiangKham Hospital
  • Kornchawan Khampa Department of Radiology, ChiangKham Hospital
  • Kaweewat Chumnumphon Department of Radiology, ChiangKham Hospital
  • Warachan Chaikanta Department of Radiology, ChiangKham Hospital
  • Namfon Piananurak Department of Radiology, ChiangKham Hospital
  • Naruenan Malairungsakul ChiangKham Hospital

Keywords:

Lung cancer screening, Chest x ray Artificial Intelligence, Low-dose computerized tomography

Abstract

This research was to survey the prevalence of lung cancer by screening with low-dose computerized tomography (LDCT) in high-risk populations and to study the factors associated with lung cancer. A cross-sectional observational pilot study was conducted in a sample of 100 Thai people who aged between 55 and 75 years-old in Chiang Kham District, Phayao Province, during August 3rd, 2024 - December 31th, 2024.
The instruments included a patient data record form and important risk factors, a digital chest X-ray (CXR AI) and a low-dose computed tomography (LDCT) result record form. We analyzed the relationship between high-risk LDCT results and other associated factors using multiple logistic regression, with statistical significance at p-value < 0.05. In the total of 100 samples, with an average age of 64 years–old, abnormal CXR AI readings were 72%. In the abnormal readings, 18% of them were lung nodules. In those lung nodule results, there was 14% of High Risk LDCT in Lung-RADS category 3 or higher. On the LDCT screening of the samples, the solid nodule was 75% of abnormal results. Most of the solid nodules were smaller than 8mm which were 36%.
A Multivariable logistic regression analysis showed the statistically significant related factor with high risk LDCT, specifically the volatile substances (OR 9.59, 95%CI 1.33-70.16, p = 0.02), alcoholic drinker (OR 7.73, 95% CI 0.86-69.63, p= 0.06) and old age (OR 1.16, 95% CI 0.99-1.35, p= 0.005). The use of CXR AI for initial screening increased the chance of detecting abnormal LDCT examination with Sensitivity Specificity 100% was 32.56%, NPV was 100%, and PPV was 19.44% respectively.

References

Siriwiwattnakul N. HOSPITAL-BASED CANCER REGISTRY 2022. Bangkok: National Cancer Institute; 2024. p.1-83.

Jayes L, Haslam PL, Gratziou CG, Powell P, Britton J, Vardavas C, et al. SmokeHaz: Systematic Reviews and Meta-analyses of the Effects of Smoking on Respiratory Health. Chest 2016;150(1):164-79.

Hill W, Lim LE, Weeden EC, Lee C, Augustine M, Chen K, et al. Lung adenocarcinoma promotion by air pollutants. Nature 2023;616(7955):159-67.

Rojanamatin J, Sangrajrang S, editors. Cancer in Thailand 2016-2018.10th ed. Bangkok: National Cancer Institute; 2021. p.1-170.

Bonney A, Malouf R, Marchal C, Manners D, Fong KM, Marshall HM, et al. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality. Cochrane Database Syst Rev 2022;8(8).

Tammemägi MC, Darling GE, Schmidt H, Walker MJ, Langer D, Leung YW, et al. Risk-based lung cancer screening performance in a universal healthcare setting. Nat Med 2024;30(4):1054-64.

Tammemägi MC. Selecting lung cancer screenees using risk prediction models-where do we go from here. Transl Lung Cancer Res 2018;7(3):243-53.

Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368(8):728-36.

Marcus MW, Chen Y, Raji OY, Duffy SW, Field JK, et al. LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence. Cancer Prev Res (Phila) 2015;8(6):570-5.

Sasieni D. editors. The Standard Protocol was developed by the NHS Cancer Programme with the CT Screening. 2nd ed. NHS England; 2022. p.1-40.

Lee JW, Kim HY, Goo JM, Kim EY, Lee SJ, Kim TJ, et al. Radiological Report of Pilot Study for the Korean Lung Cancer Screening (K-LUCAS) Project: Feasibility of Implementing Lung Imaging Reporting and Data System. Korean J Radiol 2018;19(4):803-8.

Triphuridet N, Singharuksa S, Vidhyakorn S. Practical difficulty of low dose computerized tomography as a lung cancer screening tool in an endemic area of tuberculosis. J Thorac Oncol 2017; 12(1): S568-S9.

Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS, et al. Lung cancer. Lancet 2021;398(10299):535-54.

Hussain MdS, Gupta G, Mishra R, Patel N, Gupta S, Alzarea SI, et al. Unlocking the secrets: Volatile Organic Compounds (VOCs) and their devastating effects on lung cancer. Pathol Res Pract 2024; 255:155-7.

Hamashima C. Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan. Jpn J Clin Oncol. 2018;48(3):278-86.

Chutivanidchayakul F, Suwatanapongched T, Petnak T. Clinical and chest radiographic features of missed lung cancer and their association with patient outcomes. Clin Imaging 2023; 99:73-81.

Upaisilsathaporn P, Klawandee S, Wanchaijiraboon P. The Potential of Chest X-Ray Artificial Intelligence Detecting Missed Lung Cancer Diagnosis in a Community Based Cancer in Thailand.

J Thorac Oncol 2024; 19(10): S473-S74.

ผลการอ่านภาพตรวจเอกซเรย์คอมพิวเตอร์แบบใช้ปริมาณรังสีต่ำ

Published

2025-04-30

How to Cite

1.
Thanawutthikul K, Khampa K, Chumnumphon K, Chaikanta W, Piananurak N, Malairungsakul N. Lung cancer screening in the population aged 55-75 years using low-dose computed tomography (LDCT) scan in Chiang Kham Hospital Phayao, Thailand: A Cross-Sectional Observational Pilot Study. Health Sci Tech Rev [internet]. 2025 Apr. 30 [cited 2025 Dec. 24];18(1):57-71. available from: https://li01.tci-thaijo.org/index.php/journalup/article/view/265719

Issue

Section

Research articles